Review and clinical guidelines of GLP-1 and GIP medicines in pregnancy and breastfeeding

A collaboration of researchers and clinical experts, led by the REALIFE Research Group at the Research Unit Woman and Child, Department of Development and Regeneration, KU Leuven in Belgium, have published a review and set of clinical guidelines about GLP-1 and GIP medication use in pregnancy and breastfeeding. A link to the Pubmed index here, and the article shared by one of the co-authors, ENTIS member Dr Michael Ceulemans (Research Group Clinical Pharmacology and Pharmacotherapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven).